[quote align=”center” color=”#999999″]
My time in the NIH-OxCam program has proven to be truly formative in both my personal and professional development. The program’s unique set of experiences has set the stage for an unparalleled career in translational science/medicine. Having had the opportunity to design and implement a multi-disciplinary international collaborative effort, I am now confident in my ability to drive a project to completion and in so doing shed light on translationally relevant biologic questions.
Josh started on his current trajectory into science and medicine as a biochemistry/biology dual major at Brandeis University. Following his time at Brandeis, he continued his education at Georgetown University, graduating with an MSc in physiology/biophysics. Post Georgetown, he studied at Columbia University’s Mailman School of Public Health and was credentialed with an MPH. Throughout the course of his studies, interdisciplinary research experiences in biochemistry, radiation/molecular biology, and, most recently, neuroscience have broadened his perspective and changed his conception of human diseases and how they arise.
Josh’s current scientific passion revolves around understanding the molecular mechanisms that contribute to pathology in a myriad of central nervous system diseases and disorders. Via engagement with his mentors at both the National Institute of Neurological Disorders and Stroke and the University of Cambridge, he hopes to advance neuroprotection/regenerative medicine for both patients and families in need. As an NIH-Cambridge MD/PhD Track 2 student, he will complete his PhD in Clinical Neuroscience in 2016 and return to medical school to complete his clinical clerkships.